Discovering the first microrna-targeted drug

Journal of Cell Biology

Volumn 199, Issue 3, 2012, Pages 407-412

  Lindow, Morten ^a,b   Kauppinen, Sakari ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Santaris Pharma AS   (Denmark)

^c AALBORG UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; ANTAGOMIR 122; ANTISENSE OLIGONUCLEOTIDE; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 122; MICRORNA 155; MICRORNA 15A; MICRORNA 17; MICRORNA 92; MIRAVIRSEN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTISENSE THERAPY; ANTIVIRAL ACTIVITY; ARTICLE; CAENORHABDITIS ELEGANS; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TARGETING; HEPATITIS C; HUMAN; IN SITU HYBRIDIZATION; NONHUMAN; NORTHERN BLOTTING; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPLICON; VIREMIA; ZEBRA FISH;

GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; MICRORNAS; MOLECULAR TARGETED THERAPY; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE;

HEPATITIS C VIRUS;

EID: 84869120708     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201208082     Document Type: Article

References (52)

1. Ambros, V. 2011. MicroRNAs and developmental timing. Curr. Opin. Genet. Dev. 21:511-517. http://dx.doi.org/10.1016/j.gde.2011.04.003
2. Bartel, D.P. 2009. MicroRNAs: target recognition and regulatory functions. Cell. 136:215-233. http://dx.doi.org/10.1016/j.cell.2009.01.002
3. Braasch, D.A., and D.R. Corey. 2001. Locked nucleic acid (LNA): fine-tuning the recognition of DNA and RNA. Chem. Biol. 8:1-7. http://dx.doi.org/10.1016/S1074-5521(00)00058-2
4. Bushati, N., and S.M. Cohen. 2007. microRNA functions. Annu. Rev. Cell Dev. Biol. 23:175-205. http://dx.doi.org/10.1146/annurev.cellbio.23.090506.123406
5. Calin, G.A., C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. Keating, K. Rai, et al. 2002. Frequent deletions and downregulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA. 99:15524-15529. http://dx.doi.org/10.1073/pnas.242606799
6. Cooper, C., E.J. Lawitz, P. Ghali, M. Rodriguez-Torres, F.H. Anderson, S.S. Lee, J. Bédard, N. Chauret, R. Thibert, I. Boivin, et al. 2009. Evaluation of VCH-759 monotherapy in hepatitis C infection. J. Hepatol. 51:39-46. http://dx.doi.org/10.1016/j.jhep.2009.03.015
7. Costinean, S., N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, N. Heerema, and C.M. Croce. 2006. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA. 103:7024-7029. http://dx.doi.org/10.1073/pnas.0602266103
8. Crooke, S.T. 2007. Antisense Drug Technology. 2nd ed. CRC Press, Boca Raton, FL. 848 pp.
9. Eis, P.S., W. Tam, L. Sun, A. Chadburn, Z. Li, M.F. Gomez, E. Lund, and J.E. Dahlberg. 2005. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA. 102:3627-3632. http://dx.doi.org/10.1073/pnas.0500613102
10. Elmén, J., M. Lindow, A.N. Silahtaroglu, M. Bak, M. Christensen, A. Lind-Thomsen, M. Hedtjärn, J.B. Hansen, H.F. Hansen, E.M. Straarup, et al. 2008a. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res. 36:1153-1162. http://dx.doi.org/10.1093/nar/gkm1113
11. Elmén, J., M. Lindow, S. Schütz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjärn, H.F. Hansen, U. Berger, et al. 2008b. LNA-mediated microRNA silencing in non-human primates. Nature. 452:896-899. http://dx.doi.org/10.1038/nature06783
12. Esau, C., S. Davis, S.F. Murray, X.X. Yu, S.K. Pandey, M. Pear, L. Watts, S.L. Booten, M. Graham, R. McKay, et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3:87-98. http://dx.doi.org/10.1016/j.cmet.2006.01.005
13. Friedman, R.C., K.K.-H. Farh, C.B. Burge, and D.P. Bartel. 2009. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92-105. http://dx.doi.org/10.1101/gr.082701.108
14. Gottwein, E., and B.R. Cullen. 2008. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe. 3:375-387. http://dx.doi.org/10.1016/j.chom.2008.05.002
15. He, L., J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, and S.M. Hammond. 2005. A microRNA polycistron as a potential human oncogene. Nature. 435:828-833. http://dx.doi.org/10.1038/nature03552
16. Hildebrandt-Eriksen, E.S., Y.Z. Bagger, and T.B. Knudsen. 2009. A unique therapy for HCV inhibits microRNA-122 in humans and results in HCV RNA suppression in chronically infected chimpanzees: results from primate and first-in-human studies. Hepatology. 50:12A.
17. Hildebrandt-Eriksen, E.S., V. Aarup, R. Persson, H.F. Hansen, M.E. Munk, and H. Ørum. 2012. A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys. Nucleic Acid Ther. 22:152-161.
18. Janssen, H.L., H.W. Reesink, S. Zeuzem, E. Lawitz, M. Rodriguez-Torres, A. Chen, C. Davis, B. King, A.A. Levin, and M.R. Hodges. 2011. A randomized, double-blind, placebo (plb) controlled safety and anti-viral proof of concept study of miravirsen (MIR), an oligonucleotide targeting miR-122, in treatment naïve patients with genotype 1 (gt1) chronic HCV infection. Hepatology. 54:1430A.
19. Jopling, C.L., M. Yi, A.M. Lancaster, S.M. Lemon, and P. Sarnow. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science. 309:1577-1581. http://dx.doi.org/10.1126/science.1113329
20. Kloosterman, W.P., and R.H.A. Plasterk. 2006. The diverse functions of microRNAs in animal development and disease. Dev. Cell. 11:441-450. http://dx.doi.org/10.1016/j.devcel.2006.09.009
21. Kloosterman, W.P., E. Wienholds, E. de Bruijn, S. Kauppinen, and R.H.A. Plasterk. 2006. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes. Nat. Methods. 3:27-29. http://dx.doi.org/10.1038/nmeth843
22. Koshkin, A.A., S.K. Singh, P. Nielsen, V.K. Rajwanshi, R. Kumar, M. Meldgaard, C.E. Olsen, and J. Wengel. 1998. LNA (Locked Nucleic Acids): Synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerisation, and unprecedented nucleic acid recognition. Tetrahedron. 54:3607-3630. http://dx.doi.org/10.1016/S0040-4020(98)00094-5
23. Kozomara, A., and S. Griffiths-Jones. 2011. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39(Database issue):D152-D157. http://dx.doi.org/10.1093/nar/gkq1027
24. Krek, A., D. Grün, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. MacMenamin, I. da Piedade, K.C. Gunsalus, M. Stoffel, and N. Rajewsky. 2005. Combinatorial microRNA target predictions. Nat. Genet. 37:495-500. http://dx.doi.org/10.1038/ng1536
25. Krützfeldt, J., N. Rajewsky, R. Braich, K.G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature. 438:685-689. http://dx.doi.org/10.1038/nature04303
26. Kurreck, J., E. Wyszko, C. Gillen, and V.A. Erdmann. 2002. Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30:1911-1918. http://dx.doi.org/10.1093/nar/30.9.1911
27. Lagos-Quintana, M., R. Rauhut, W. Lendeckel, and T. Tuschl. 2001. Identification of novel genes coding for small expressed RNAs. Science. 294:853-858. http://dx.doi.org/10.1126/science.1064921
28. Lagos-Quintana, M., R. Rauhut, A. Yalcin, J. Meyer, W. Lendeckel, and T. Tuschl. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735-739. http://dx.doi.org/10.1016/S0960-9822(02)00809-6
29. Lanford, R.E., E.S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, M.E. Munk, S. Kauppinen, and H. Ørum. 2010. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 327:198-201. http://dx.doi.org/10.1126/science.1178178
30. Lau, N.C., L.P. Lim, E.G. Weinstein, and D.P. Bartel. 2001. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science. 294:858-862. http://dx.doi.org/10.1126/science.1065062
31. Lee, R.C., and V. Ambros. 2001. An extensive class of small RNAs in Caenorhabditis elegans. Science. 294:862-864. http://dx.doi.org/10.1126/science.1065329
32. Lee, R.C., R.L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843-854. http://dx.doi.org/10.1016/0092-8674(93)90529-Y
33. Leuschner, P.J.F., S.L. Ameres, S. Kueng, and J. Martinez. 2006. Cleavage of the siRNA passenger strand during RISC assembly in human cells. EMBO Rep. 7:314-320. http://dx.doi.org/10.1038/sj.embor.7400637
34. Lewis, B.P., C.B. Burge, and D.P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15-20. http://dx.doi.org/10.1016/j.cell.2004.12.035
35. Li, Y.P., J.M. Gottwein, T.K. Scheel, T.B. Jensen, and J. Bukh. 2011. MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR. Proc. Natl. Acad. Sci. USA. 108:4991-4996. http://dx.doi.org/10.1073/pnas.1016606108
36. Ma, J.-B., Y.-R. Yuan, G. Meister, Y. Pei, T. Tuschl, and D.J. Patel. 2005. Structural basis for 5'-end-specific recognition of guide RNA bythe A. fulgidus Piwi protein. Nature. 434:666-670. http://dx.doi.org/10.1038/nature03514
37. Machlin, E.S., P. Sarnow, and S.M. Sagan. 2011. Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNAtarget RNA complex. Proc. Natl. Acad. Sci. USA. 108:3193-3198. http://dx.doi.org/10.1073/pnas.1012464108
38. Matranga, C., Y. Tomari, C. Shin, D.P. Bartel, and P.D. Zamore. 2005. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell. 123:607-620. http://dx.doi.org/10.1016/j.cell.2005.08.044
39. Mendell, J.T., and E.N. Olson. 2012. MicroRNAs in stress signaling and human disease. Cell. 148:1172-1187. http://dx.doi.org/10.1016/j.cell.2012.02.005
40. Orom, U.A., S. Kauppinen, and A.H. Lund. 2006. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene. 372:137-141. http://dx.doi.org/10.1016/j.gene.2005.12.031
41. Parker, J.S., S.M. Roe, and D. Barford. 2005. Structural insights into mRNA recognition from a PIWI domain-siRNA guide complex. Nature. 434:663-666. http://dx.doi.org/10.1038/nature03462
42. Pasquinelli, A.E., B.J. Reinhart, F. Slack, M.Q. Martindale, M.I. Kuroda, B. Maller, D.C. Hayward, E.E. Ball, B. Degnan, P. Müller, et al. 2000. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature. 408:86-89. http://dx.doi.org/10.1038/35040556
43. Reinhart, B.J., F.J. Slack, M. Basson, A.E. Pasquinelli, J.C. Bettinger, A.E. Rougvie, H.R. Horvitz, and G. Ruvkun. 2000. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 403:901-906. http://dx.doi.org/10.1038/35002607
44. Shimakami, T., D. Yamane, C. Welsch, L. Hensley, R.K. Jangra, and S.M. Lemon. 2012. Base pairing between hepatitis C virus RNA and microRNA 122 3' of its seed sequence is essential for genome stabilization and production of infectious virus. J. Virol. 86:7372-7383. http://dx.doi.org/10.1128/JVI.00513-12
45. Stenvang, J., A. Petri, M. Lindow, S. Obad, and S. Kauppinen. 2012. Inhibition of microRNA function by antimiR oligonucleotides. Silence. 3:1. http://dx.doi.org/10.1186/1758-907X-3-1
46. Válóczi, A., C. Hornyik, N. Varga, J. Burgyán, S. Kauppinen, and Z. Havelda. 2004. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes. Nucleic Acids Res. 32:e175. http://dx.doi.org/10.1093/nar/gnh171
47. Válóczi, A., E. Várallyay, S. Kauppinen, J. Burgyán, and Z. Havelda. 2006. Spatio-temporal accumulation of microRNAs is highly coordinated in developing plant tissues. Plant J. 47:140-151. http://dx.doi.org/10.1111/j.1365-313X.2006.02766.x
48. van Rooij, E., A.L. Purcell, and A.A. Levin. 2012. Developing microRNA therapeutics. Circ. Res. 110:496-507. http://dx.doi.org/10.1161/CIRCRESAHA.111.247916
49. Ventura, A., and T. Jacks. 2009. MicroRNAs and cancer: short RNAs go a long way. Cell. 136:586-591. http://dx.doi.org/10.1016/j.cell.2009.02.005
50. Wienholds, E., W.P. Kloosterman, E. Miska, E. Alvarez-Saavedra, E. Berezikov, E. de Bruijn, H.R. Horvitz, S. Kauppinen, and R.H.A. Plasterk. 2005. MicroRNA expression in zebrafish embryonic development. Science. 309:310-311. http://dx.doi.org/10.1126/science.1114519
51. Wightman, B., I. Ha, and G. Ruvkun. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 75:855-862. http://dx.doi.org/10.1016/0092-8674(93)90530-4
52. Williams, A.H., N. Liu, E. van Rooij, and E.N. Olson. 2009. MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 21:461-469. http://dx.doi.org/10.1016/j.ceb.2009.01.029